POSA26 Sunitinib Treatment Modification in First-line Metastatic Renal Cell Carcinoma: Analysis of a Real-World Swedish Cohort

Abstract

Authors

M Jakobsson F Nilsson A Strambi J Arpegård J Dalén

Full Text Cite This Article
Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×